Storia in 2 fonti

Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn

Natco Pharma invests $14 million in eGenesis, raising total funding to $22 million for innovative organ transplantation solutions.

Raccontata da

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindu.comStai leggendo20 h fa

Natco Pharma invests $14 million in eGenesis, raising total funding to $22 million for innovative organ transplantation solutions.

Natco Pharma invests $14 million in eGenesis to advance innovative organ transplant technology and address global organ shortages.